{"SPADE_UN_15517": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15517", "Peptide Name": "[D-Trp]CJ-15,208", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "FPFW", "Sequence Length": 4, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:PC-3 (IC50=16.5±0.7 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Lactam", "C-terminal Modification": "Lactam", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C18H16N2O", "Mass": 595.69, "PI": 5.53, "Net Charge": 0, "Hydrophobicity": 0.77, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth", "Pubmed ID": "28692379", "Reference": "Cancer Biol Ther. 2017 Aug 3;18(8)571-583.", "Author": "Mukhopadhyay A, Hanold LE, Thayele Purayil H, Gisemba SA, Senadheera SN, Aldrich JV.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28692379"}], "Frequent Amino Acids": "FPW", "Absent Amino Acids": "ACDEGHIKLMNOQRSTUVY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 4, "Polar Residues": 0, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02179", "Similarity": 1.0, "Sequence": "KFFKKLKNSVKKRAKKFFKKPKVIGVTFPF"}, {"SPADE_ID": "SPADE_N_02202", "Similarity": 1.0, "Sequence": "KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF"}, {"SPADE_ID": "SPADE_N_05729", "Similarity": 1.0, "Sequence": "KHFGKDSNFPF"}]}}}